Advertisement

Integrated electrophysiology care for patients with heart failure: An envisioned future

Published:October 12, 2020DOI:https://doi.org/10.1016/j.hrthm.2020.10.008
      Heart failure (HF) is a chronic, progressive, and complex disease that is increasing in prevalence with a projected 46% increase from 2012 to 2030.
      • Heidenreich P.A.
      • Albert N.M.
      • Allen L.A.
      • et al.
      American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association.
      Frequent hospital admissions have made HF one of the leading causes of health care expenditures, costing the system more than 30 billion US dollars a year.
      • Heidenreich P.A.
      • Trogdon J.G.
      • Khavjou O.A.
      • et al.
      Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association.
      Many of these patients have cardiac implantable electronic devices (CIEDs), wearable devices, and atrial and ventricular arrhythmias. There is an increasing focus on how to best manage these patients, with the recognition that an integrated care model is optimal.

      Keywords

      Abbreviations:

      AF (atrial fibrillation), APP (advanced practice provider), CIED (cardiac implantable electronic device), CRT (cardiac resynchronization therapy), EP (electrophysiology), HF (heart failure), ICD (implantable cardioverter-defibrillator), LVAD (left ventricular assist device), PVC (premature ventricular contraction), VT (ventricular tachycardia)
      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Heidenreich P.A.
        • Albert N.M.
        • Allen L.A.
        • et al.
        American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association.
        Circ Heart Fail. 2013; 6: 606-619
        • Heidenreich P.A.
        • Trogdon J.G.
        • Khavjou O.A.
        • et al.
        Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association.
        Circulation. 2011; 123: 933-944
        • Nelson C.A.
        • Park C.K.
        • Gates R.J.
        • Arreguin M.E.
        • Salsa T.M.
        • Miller H.B.
        Clinical and economic impact of an integrated care team model on targeted, high-risk Medicare patients with type 2 diabetes.
        Clin Diabetes. 2018; 36: 313-318
        • Huber C.A.
        • Oliver Reich
        • Fruh M.
        • Rosemann T.
        Effects of integrated care of disease-related hospitalisation and healthcare costs in patients with diabetes, cardiovascular diseases and respiratory illnesses: A propensity-matched cohort study in Switzerland.
        Int J Integr Care. 2016; 16: 1-18
        • Epstein N.
        Multidisciplinary in-hospital teams improve patient outcomes: A review.
        Surg Neurol Int. 2014; 5: 295-303
        • Gallagher C.
        • Elliott A.D.
        • Wong C.X.
        • et al.
        Integrated care in atrial fibrillation: A systematic review and meta-analysis.
        Heart. 2017; 103: 1947-1953
        • Barac A.
        • Murtagh G.
        • Carver J.R.
        • et al.
        Cardiovascular health of patients with cancer and cancer survivors: A roadmap to the next level.
        J Am Coll Cardiol. 2015; 65: 2739-2746
        • Gujral D.M.
        • Lloyd G.
        • Bhattacharyya S.
        Provision and clinical utility of cardio-oncology services for detection of cardiac toxicity in cancer patients.
        J Am Coll Cardiol. 2016; 67: 1499-1500
        • Nutt M.
        • Hungerford C.
        Nurse care coordinators: Definitions and scope of practice.
        Contemp Nurse. 2010; 36: 71-81
        • Piccini J.P.
        • Mittal S.
        • Snell J.
        • Prillinger J.B.
        • Dalal N.
        • Vrma N.
        Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment.
        Heart Rhythm. 2016; 13: 2279-2286
        • Andersen T.O.
        • Nielsen K.D.
        • Moll J.
        • Svendsen J.H.
        Unpacking telemonitoring work: Workload and telephone calls to patients in implanted cardiac device care.
        Int J Med Inform. 2019; 129: 381-387
        • Morgan J.M.
        • Kitt S.
        • Gill J.
        • et al.
        Remote management of heart failure using implantable electronic devices.
        Eur Heart J. 2017; 38: 2352-2360
        • Gula L.J.
        • Wells G.A.
        • Yee R.
        • et al.
        A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: validation from RAFT.
        Heart Rhythm. 2014; 11: 1626-1631
        • Gardner R.S.
        • Singh J.P.
        • Stancak B.
        • et al.
        HeartLogic multisensor algorithm identifies patients during periods of significantly increased risk of heart failure events: Results from the MultiSENSE study.
        Circ Heart Fail. 2018; 11e004669
        • Ollendorf D.A.
        • Sandhu A.T.
        • Pearson S.D.
        CardioMEMS HF for the management of heart failure-effectiveness and value.
        JAMA Intern Med. 2016; 176: 1551-1552
        • Palfy J.A.
        • Benezet-Mazuecos J.
        • Martinez Milla J.
        • et al.
        CorVue algorithm efficacy to predict heart failure in real life: Unnecessary and potentially misleading information? Pacing Clin Electrophysiol. Published online June 1, 2018.
        • Cheng A.
        • Landman S.R.
        • Stadler R.W.
        Reasons for loss of cardiac resynchronization therapy pacing: Insights from 32 844 patients.
        Circ Arrhythm Electrophysiol. 2012; 5: 884-888
        • Auricchio A.
        • Prinzen F.W.
        Enhancing response in the cardiac resynchronization therapy patient: The 3B perspective-bench, bits, and bedside.
        JACC Clin Electrophysiol. 2017; 3: 1203-1219
        • Altman R.K.
        • Parks K.A.
        • Schlett C.L.
        • et al.
        Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.
        Eur Heart J. 2012; 33: 2181-2188
        • Mullens W.
        • Grimm R.A.
        • Verga T.
        • et al.
        Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.
        J Am Coll Cardiol. 2009; 53: 765-773
        • Marrouche N.F.
        • Brachmann J.
        • Andresen D.
        • et al.
        • CASTLE-AF Investigators
        Catheter ablation for atrial fibrillation with heart failure.
        N Engl J Med. 2018; 378: 417-427
        • Vegh E.M.
        • Sood N.
        • Singh J.P.
        The role of ablation of the atrioventricular junction in patients with heart failure and atrial fibrillation.
        Heart Fail Clin. 2013; 9: 489-499, ix
        • Berruezo A.
        • Penela D.
        • Jáuregui B.
        • et al.
        Mortality and morbidity reduction after frequent premature ventricular complexes ablation in patients with left ventricular systolic dysfunction.
        Europace. 2019; 21: 1079-1087
        • Wilkoff B.L.
        • Cook J.R.
        • Epstein A.E.
        • et al.
        Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial.
        JAMA. 2002; 288: 3115-3123
        • Bonow R.O.
        • Msaoudi F.A.
        • Rumsfeld J.S.
        • et al.
        ACC/AHA classification of care metrics: Performance measures and quality metrics.
        J Am Coll Cardiol. 2008; 52: 2113-2117
        • Stamou S.C.
        • Camp S.L.
        • Reames M.K.
        • et al.
        Continuous quality improvement program and major morbidity after cardiac surgery.
        Am J Cardiol. 2008; 102: 772-777
        • Jessup M.
        • Ardehali R.
        • Konstam M.A.
        • et al.
        COCATS 4 Task Force 12: Training in heart failure.
        J Am Coll Cardiol. 2015; 65: 1866-1876
        • Calkins H.
        • Awtry E.H.
        • Bunch T.J.
        • Kaul S.
        • Miller J.M.
        • Tedrow U.B.
        COCATS 4 Task Force 11: Training in arrhythmia diagnosis and management, cardiac pacing, and electrophysiology.
        J Am Coll Cardiol. 2015; 65: 1854-1865
        • Patton K.K.
        • Fisher J.D.
        • Lindsay B.
        • McDonald F.S.
        • Tedrow U.B.
        • Calkins H.
        COCATS 4, the 2015 CCEP advanced training statement, and the transition from 12 to 24 required months of electrophysiology training: Rationale, status, and implications for the future.
        JACC Clin Electrophysiol. 2016; 2: 120-123
        • Jessup M.
        • Drazner M.H.
        • Book W.
        • et al.
        2017 ACC/AHA/HFSA/ISHLT/ACP advanced training statement on advanced heart failure and transplant cardiology (revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant): A report of the ACC Competency Management Committee.
        J Am Coll Cardiol. 2017; 69: 2977-3001
      1. American Nurses Credentialing Center.
        (Accessed May 31, 2020)
      2. NCCPA.
        (Accessed May 31, 2020)
        • International Board of Heart Rhythm Examiners
        (Accessed May 31, 2020)
      3. American Associated of Heart Failure Nurses Certification Board. CHFN and CHFN-K Examination.
        (Accessed May 31, 2020)
        • Board E.S.C.
        The future of continuing medical education: The roles of medical professional societies and the health care industry: Position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, endorsed by the Board of the European Society of Cardiology.
        Eur Heart J. 2019; 40: 1720-1727
        • Institute of Medicine of the National Academies
        Lo B. Field M.J. Conflict of Interest in Medical Research, Education, and Practice. National Academies Press, 2009
        • Steinman M.A.
        • Landefeld C.S.
        • Baron R.B.
        Industry support of CME—are we at the tipping point?.
        N Engl J Med. 2012; 366: 1069-1071
        • Timmermans I.
        • Meine M.
        • Szendey I.
        • et al.
        Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow-up.
        Pacing Clin Electrophysiol. 2019; 42: 120-129
        • Centers for Medicare & Medicaid Services
        Decision memo for implantable cardioverter defibrillators (CAG-00157R4).
        (Accessed May 31, 2020)
        • Elwyn G.
        • Frosch D.
        • Thomson R.
        • et al.
        Shared decision making: a model for clinical practice.
        J Gen Intern Med. 2012; 27: 1361-1367
        • Wasserlauf J.
        • You C.
        • Patel R.
        • Valys A.
        • Albert D.
        • Passman R.
        Smartwatch performance for the detection and quantification of atrial fibrillation.
        Circ Arrhythm Electrophysiol. 2019; 12e006834
        • Yanicelli L.M.
        • Goy C.B.
        • González V.D.C.
        • Palacios G.N.
        • Martínez E.C.
        • Herrera M.C.
        Non-invasive home telemonitoring system for heart failure patients: A randomized clinical trial.
        J Telemed Telecare. Published online January. 2020; 23 (https://doi.org/10.1177/1357633X19899261)
        • Chang S.
        Nobody wants a waiting room.
        (Accessed May 31, 2020)
        • Kusumoto F.M.
        • Hao S.C.
        • Slotwiner D.J.
        • et al.
        Arrhythmia care in a value-based environment: Past, present, and future.
        Heart Rhythm. 2018; 15: e5-e15
        • Naccarelli G.V.
        Does it make sense to train plumbers as electricians?.
        J Am Coll Cardiol. 2004; 44: 1358-1360
        • Singh J.P.
        Electrical therapy for advanced heart failure: Is it time for a multidisciplinary approach or a new subspecialty?.
        Expert Rev Cardiovasc Ther. 2007; 5: 811-815
        • Heist E.K.
        • Herre J.M.
        • Binkley P.F.
        • et al.
        Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study).
        Am J Cardiol. 2014; 114: 1249-1256
        • Domenichini G.
        • Rahneva T.
        • Diab I.G.
        • et al.
        The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
        Europace. 2016; 18: 428-435
        • Hindricks G.
        • Taborsky M.
        • Glikson M.
        • et al.
        IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): A randomised controlled trial.
        Lancet. 2014; 384: 583-590
        • Hindricks G.
        • Varma N.
        • Kacet S.
        • et al.
        Daily remote monitoring of implantable cardioverter-defibrillators: Insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST).
        Eur Heart J. 2017; 38: 1749-1755
        • Boehmer J.P.
        • Hariharan R.
        • Devecchi F.G.
        • et al.
        A multisensor algorithm predicts heart failure events in patients with implanted devices: Results from the MultiSENSE study.
        JACC Heart Fail. 2017; 5: 216-225
        • Hatlestad J.
        • Mehta S.
        • Whelan-Schwartz J.
        • Shankar R.
        • Boehmer J.P.
        Night-time elevation angles in MultiSENSE study are related to symptoms of orthopnea & paroxysmal nocturnal dyspnea.
        J Card Fail. 2012; 18: S8
        • Rials S.J.
        • Hatlestad J.D.
        • Smith A.
        • Pubbi D.
        • Slotwiner D.J.
        • Boehmer J.P.
        Night-time elevation angle in heart failure patients indicates orthopnea and paroxysmal nocturnal dyspnea.
        J Card Fail. 2017; 23: S81
      4. Precision Event Monitoring for Patients With Heart Failure Using HeartLogic (PREEMPT-HF). ClinicalTrials.gov. identifier: NCT03579641.
        (Updated May 12, 2020. Accessed May 31, 2020)
      5. Multiple Cardiac Sensors for the Management of Heart Failure (MANAGE-HF). ClinicalTrials.gov. identifier: NCT03237858.
        (Updated May 12, 2020. Accessed May 31, 2020)
        • Van Veldhuisen D.J.
        • Braunschweig F.
        • Conraads V.
        • et al.
        Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
        Circulation. 2011; 124: 1719-1726
        • Conraads V.M.
        • Tavazzi L.
        • Santini M.
        • et al.
        Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
        Eur Heart J. 2011; 32: 2266-2273
        • Whellan D.J.
        • Ousdigian K.T.
        • Al-Khatib S.M.
        • et al.
        Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
        J Am Coll Cardiol. 2010; 55: 1803-1810